vs
Apyx Medical Corp（APYX）与ASP Isotopes Inc.（ASPI）财务数据对比。点击上方公司名可切换其他公司
Apyx Medical Corp的季度营收约是ASP Isotopes Inc.的1.2倍（$19.2M vs $16.7M），ASP Isotopes Inc.同比增速更快（1295.7% vs 34.7%），Apyx Medical Corp自由现金流更多（$-2.8M vs $-47.4M）
Apyx Medical前身是博维医疗，是美国的医疗器械制造商，专注生产电外科产品与能源技术相关医疗设备，公司总部位于佛罗里达州克利尔沃特，在保加利亚设有生产工厂。
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
APYX vs ASPI — 直观对比
营收规模更大
APYX
是对方的1.2倍
$16.7M
营收增速更快
ASPI
高出1260.9%
34.7%
自由现金流更多
APYX
多$44.6M
$-47.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.2M | $16.7M |
| 净利润 | $-1.3M | — |
| 毛利率 | 62.6% | 12.5% |
| 营业利润率 | 0.1% | — |
| 净利率 | -6.8% | — |
| 营收同比 | 34.7% | 1295.7% |
| 净利润同比 | 71.9% | -586.8% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APYXASPI
| Q4 25 | $19.2M | $16.7M | ||
| Q3 25 | $12.9M | $4.9M | ||
| Q2 25 | $11.4M | — | ||
| Q1 25 | $9.4M | — | ||
| Q4 24 | $14.2M | — | ||
| Q3 24 | $11.5M | — | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $10.2M | — |
净利润APYXASPI
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $-2.0M | $-12.9M | ||
| Q2 25 | $-3.8M | — | ||
| Q1 25 | $-4.2M | — | ||
| Q4 24 | $-4.6M | — | ||
| Q3 24 | $-4.7M | — | ||
| Q2 24 | $-6.6M | — | ||
| Q1 24 | $-7.6M | — |
毛利率APYXASPI
| Q4 25 | 62.6% | 12.5% | ||
| Q3 25 | 64.4% | 8.7% | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
营业利润率APYXASPI
| Q4 25 | 0.1% | — | ||
| Q3 25 | -6.5% | -306.1% | ||
| Q2 25 | -22.6% | — | ||
| Q1 25 | -32.4% | — | ||
| Q4 24 | -21.4% | — | ||
| Q3 24 | -31.6% | — | ||
| Q2 24 | -45.7% | — | ||
| Q1 24 | -64.6% | — |
净利率APYXASPI
| Q4 25 | -6.8% | — | ||
| Q3 25 | -15.4% | -263.7% | ||
| Q2 25 | -33.2% | — | ||
| Q1 25 | -44.0% | — | ||
| Q4 24 | -32.5% | — | ||
| Q3 24 | -40.9% | — | ||
| Q2 24 | -54.0% | — | ||
| Q1 24 | -74.0% | — |
每股收益（稀释后）APYXASPI
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.15 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-0.19 | — | ||
| Q1 24 | $-0.22 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.7M | $333.3M |
| 总债务越低越好 | $37.5M | $14.4M |
| 股东权益账面价值 | $14.5M | $204.2M |
| 总资产 | $66.8M | $498.0M |
| 负债/权益比越低杠杆越低 | 2.58× | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资APYXASPI
| Q4 25 | $31.7M | $333.3M | ||
| Q3 25 | $25.1M | $113.9M | ||
| Q2 25 | $29.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $31.7M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $32.7M | — | ||
| Q1 24 | $37.3M | — |
总债务APYXASPI
| Q4 25 | $37.5M | $14.4M | ||
| Q3 25 | $37.5M | $13.9M | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益APYXASPI
| Q4 25 | $14.5M | $204.2M | ||
| Q3 25 | $5.8M | $74.1M | ||
| Q2 25 | $7.3M | — | ||
| Q1 25 | $10.5M | — | ||
| Q4 24 | $14.2M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $14.7M | — | ||
| Q1 24 | $20.3M | — |
总资产APYXASPI
| Q4 25 | $66.8M | $498.0M | ||
| Q3 25 | $57.4M | $225.9M | ||
| Q2 25 | $58.2M | — | ||
| Q1 25 | $60.2M | — | ||
| Q4 24 | $64.8M | — | ||
| Q3 24 | $60.7M | — | ||
| Q2 24 | $65.4M | — | ||
| Q1 24 | $70.7M | — |
负债/权益比APYXASPI
| Q4 25 | 2.58× | 0.07× | ||
| Q3 25 | 6.41× | 0.19× | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.5M | $-37.8M |
| 自由现金流经营现金流 - 资本支出 | $-2.8M | $-47.4M |
| 自由现金流率自由现金流/营收 | -14.6% | -284.7% |
| 资本支出强度资本支出/营收 | 1.4% | 57.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.1M | — |
8季度趋势，按日历期对齐
经营现金流APYXASPI
| Q4 25 | $-2.5M | $-37.8M | ||
| Q3 25 | $-3.5M | $-8.9M | ||
| Q2 25 | $-1.2M | — | ||
| Q1 25 | $-702.0K | — | ||
| Q4 24 | $-2.9M | — | ||
| Q3 24 | $-4.4M | — | ||
| Q2 24 | $-4.3M | — | ||
| Q1 24 | $-6.3M | — |
自由现金流APYXASPI
| Q4 25 | $-2.8M | $-47.4M | ||
| Q3 25 | $-4.1M | $-12.0M | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
自由现金流率APYXASPI
| Q4 25 | -14.6% | -284.7% | ||
| Q3 25 | -31.5% | -245.5% | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
资本支出强度APYXASPI
| Q4 25 | 1.4% | 57.9% | ||
| Q3 25 | 4.0% | 64.4% | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
